OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients

BACKGROUND AND OBJECTIVE: Liver cancer is a highly malignant tumor, and patients typically have poor prognoses. Metabolic reprogramming is a hallmark of cancer, and downregulation of oxoglutarate dehydrogenase-like (OGDHL) contributes to the onset and progression of several cancers. We examined the...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Dis Markers
Hoofdauteurs: Jiao, Yan, Li, Yanqing, Fu, Zhuo, Hou, Lin, Chen, Qingmin, Cai, Yujie, Jiang, Peiqiang, He, Miao, Yang, Zhaoying
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Hindawi 2019
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6855184/
https://ncbi.nlm.nih.gov/pubmed/31781311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/9037131
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items